Page 19 - Read Online

Nagayama. J Cancer Metastasis Treat 2021;7:6 I http://dx.doi.org/10.20517/2394-4722.2020.114 Page 15 of 16

68. Yi HQ, Ye T, Ge MH, et al. Inhibition of autophagy enhances the targeted therapeutic effect of sorafenib in thyroid cancer. Oncol Rep
2018;39:711-20.
69. Fan D, Liu SY, van Hasselt CA, et al. Estrogen receptor alpha induces prosurvival autophagy in papillary thyroid cancer via stimulating
reactive oxygen species and extracellular signal regulated kinases. J Clin Endocrinol Metab 2015;100:E561-71.
70. Wang WB, Kang H, Zhao YN, et al. Targeting autophagy sensitizes BRAF-mutant thyroid cancer to vemurafenib. J Clin Endocrinol
Metab 2017;102:634-43.
71. Feng HR, Cheng X, Kuang J, et al. Apatinib-induced protective autophagy and apoptosis through the AKT-mTOR pathway in anaplastic
thyroid cancer. Cell Death Dis 2018;9:1030.
72. Meng XR, Wang HJ, Zhao JZ, et al. Apatinib inhibits cell proliferation and induces autophagy in human papillary thyroid carcinoma via
the PI3K/Akt/mTOR signaling pathway. Front Oncol 2020;10:217.
73. Li XB, Li ZZ, Song YM, Liu WG, Liu ZW. The mTOR kinase inhibitor CZ415 inhibits human papillary thyroid carcinoma cell growth.
Cell Physiol Biochem 2018;46:579-90.
74. Gao P, Hao FJ, Dong X, Qiu Y. The role of autophagy and Beclin-1 in radiotherapy-induced apoptosis in thyroid carcinoma cells. Int J
Clin Exp Pathol 2019;12:885-92.
75. Zhang L, Cheng X, Gao YY, et al. Apigenin induces autophagic cell death in human papillary thyroid carcinoma BCPAP cells. Food
Funct 2015;6:3464-72.
76. Run L, Wang LP, Nong XT, Li N, Huang X, Xiao Y. Involvement of HMGB1 in vemurafenib resistance in thyroid cancer cells harboring
BRAF (V600E) mutation by regulating excessive autophagy. Endocrine 2020.
77. Morgan MJ, Fitzwalter BE, Owens CR, et al. Metastatic cells are preferentially vulnerable to lysosomal inhibition. Proc Natl Acad Sci U
S A 2018;115:E8479-e88.
78. Maycotte P, Aryal S, Cummings CT, et al. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy.
Autophagy 2012;8:200-12.
79. Lee HO, Mustafa A, Hudes GR, Kruger WD. Hydroxychloroquine destabilizes phospho-S6 in human renal carcinoma cells. PLoS One
2015;10:e0131464.
80. Liu J, Feng LG, Zhang HT, et al. Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by
autophagy regulation. Cancer Biol Ther 2018;19:484-96.
81. Zhang Y, Yang WQ, Zhu H, et al. Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin.
Biochem Pharmacol 2014;87:562-70.
82. He Q, Liu WP, Sha S, et al. Adenosine 5’-monophosphate-activated protein kinase-dependent mTOR pathway is involved in flavokawain
B-induced autophagy in thyroid cancer cells. Cancer Sci 2018;109:2576-89.
83. Li S, Zhang HY, Wang T, et al. BAG3 promoted starvation-induced apoptosis of thyroid cancer cells via attenuation of autophagy. J Clin
Endocrinol Metab 2014;99:E2298-307.
84. Zhao YN, Wang WB, Min I, et al. BRAF V600E-dependent role of autophagy in uveal melanoma. J Cancer Res Clin Oncol
2017;143:447-55.
85. Liu KP, Yu QG, Li H, et al. BIRC7 promotes epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma through
restraining autophagy. Am J Cancer Res 2020;10:78-94.
86. Shen H, Lin ZK, Shi HY, et al. MiR-221/222 promote migration and invasion, and inhibit autophagy and apoptosis by modulating ATG10
in aggressive papillary thyroid carcinoma. 3 Biotech 2020;10:339.
87. Khan AQ, Mohamed EAN, Hakeem I, et al. Sanguinarine induces apoptosis in papillary thyroid cancer cells via generation of reactive
oxygen species. Molecules 2020;25:1229.
88. Yu HI, Shen HC, Chen SH, et al. Autophagy modulation in human thyroid cancer cells following aloperine treatment. Int J Mol Sci
2019;20.
89. Xiang YF, Zhao JQ, Zhao M, Wang KJ. Allicin activates autophagic cell death to alleviate the malignant development of thyroid cancer.
Exp Ther Med 2018;15:3537-43.
90. Long HL, Zhang FF, Wang HL, et al. Mulberry anthocyanins improves thyroid cancer progression mainly by inducing apoptosis and
autophagy cell death. Kaohsiung J Med Sci 2018;34:255-62.
91. Qin Y, Sun W, Zhang H, et al. LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid
cancer. Endocrine 2018;59:555-64.
92. Lin CI, Whang EE, Abramson MA, et al. Autophagy: a new target for advanced papillary thyroid cancer therapy. Surgery
2009;146:1208-14.
93. Lin CI, Whang EE, Donner DB, et al. Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met
inhibition in papillary thyroid cancer. Mol Cancer Res 2010;8:1217-26.
94. Yang Z, Huang RH, Wei XY, Yu WP, Min ZJ, Ye M. The SIRT6-Autophagy-Warburg effect axis in papillary thyroid cancer. Front Oncol
2020;10:1265.
95. Xu XH, Bucala R, Ren J. Macrophage migration inhibitory factor deficiency augments doxorubicin-induced cardiomyopathy. J Am Heart
Assoc 2013;2:e000439-e.
96. Kawaguchi T, Takemura G, Kanamori H, et al. Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of
autophagy in affected cardiomyocytes. Cardiovasc Res 2012;96:456-65.
97. Li DL, Wang ZV, Ding G, et al. Doxorubicin blocks cardiomyocyte autophagic flux by inhibiting Lysosome acidification. Circulation
2016;133:1668-87.